openPR Logo
Press release

Dermatological Products Market Study Reveals Growth Factors and Competitive Outlook for Future || Key Players - keda Mohando Co Ltd, Johnson & Johnson Consumer Ltd, Bayer AG, Taisho Pharmaceutical, Merck & Co. Inc.

07-11-2019 12:08 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Dermatological Products Market Study Reveals Growth Factors

The report on the Dermatological Products Market provides a detailed analysis of the market, along with information on the most interesting developments in the dermatological products market across the globe. The report provides an overview of the dermatological products market, analysis of the trends, and identification of new opportunities in the dermatological products market.

Biologic agents or protein-based drugs are increasingly used in dermatology for treatment of psoriasis. These products have also gained traction in the treatment of other inflammatory skin diseases. Treatment of psoriasis is the largest area of development for dermatological biologics. There are around 10 approved biologics in the dermatological products market to treat moderate to severe psoriasis.

With advancement in biomedical science, manufacturers in dermatological products market are using new technologies such as bioinformatics, biomarkers, nanotechnology, and molecular targeting for medicine discovery. Production of biosimilars is likely to increase in dermatological products market as these drugs have similar active ingredients to biologic medicines and are more cost-effective.

Request Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2363

North America is expected to witness significant growth in the demand and sales of dermatological products in 2018. Growing number of skin diseases across all age groups in the US is likely to create growth opportunities for manufacturers in the dermatological products market in the region.

According to the American Academy of Dermatology, acne is the most common skin condition in the US, affecting around 50 million people every year. Moreover, nearly 7.5 million people in the US suffer from psoriasis. Majority of dermatological products treating acne, psoriasis, and other skin conditions have been approved by Food and Drug Administration (FDA) in last few years, while many dermatological products are still under process of approval.

In Canada, UV exposure is emerging as the growing risk resulting in melanoma as fastest rising cancers. According to the research by Canadian Dermatology Association (CDA), use of sunscreen continues to rise in Canada. In 2017, among 15-29 years of age group, around 7% of new melanoma cancer cases were registered in Canada.

Canadian consumers are also moving towards adopting premium skin care dermatological products with high quality of natural ingredients. Dermatological products including facial oils, masks, and serums are gaining immense popularity among consumers in Canada.

Acne Treatment Products to Witness Surge in Demand

Demand for acne treatment dermatological products is projected to witness robust growth in the coming years. Increasing cases of acne worldwide, coupled with innovation in acne treatment is expected to drive demand for acne treatment products. Increasing research activities along with better understanding of pathology of acne is likely to result in new and safer acne treatment products by manufacturers in the dermatological products market.

Targeting inflammatory mechanisms with disease modifying ability, biologics is finding large application in development of acne treatment products. Acne is affecting increasing number of adolescents and young adults. According to the American Academy of Dermatology, acne is increasing among women, affecting nearly 15% of women in the US.

Currently, topical drugs or topical therapy are widely used by increasing number of people in acne treatment across the world. As per the study by Fact.MR, acne treatment products are expected to bring in more than US$ 3,000 million by 2018 end. Meanwhile, scar and stretch mark products are also likely to witness increasing demand in the dermatological products market owing to rise in accidents, surgeries, and rise in consciousness among pregnant women on developing stretch marks.

Have Any Query? Ask Our Industry Experts @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=2363

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatological Products Market Study Reveals Growth Factors and Competitive Outlook for Future || Key Players - keda Mohando Co Ltd, Johnson & Johnson Consumer Ltd, Bayer AG, Taisho Pharmaceutical, Merck & Co. Inc. here

News-ID: 1801837 • Views:

More Releases from Fact.MR

Busbar Trunking System Market Expected to Grow at 6.1% CAGR from 2024 to 2034
Busbar Trunking System Market Expected to Grow at 6.1% CAGR from 2024 to 2034
The global busbar trunking system market (バスバートランキングシステム市場) size is expected to be worth US$ 6,520.2 million in 2024. The market is anticipated to expand at a CAGR of 6.1% from 2024 to 2034. The market is predicted to surpass a valuation of US$ 11,787.3 million by 2034. The growth of the busbar trunking system market is driven by the rising adoption of renewable energy sources and the demand for smart
Polyethylene Wax Market Size Assessment and 5.1% CAGR Expansion (2024-2034)
Polyethylene Wax Market Size Assessment and 5.1% CAGR Expansion (2024-2034)
The global polyethylene wax market (ポリエチレンワックス市場) is projected to grow at a CAGR of 5.1% from 2024 to 2034, following its 2024 size of US$ 1.1 billion. Companies prioritize sustainable growth, leading polyethylene wax manufacturers to adopt biodegradable formulations. These eco-friendly waxes are sought after by industries aiming to reduce their carbon footprints. An example is Novaspers C1491, a biodegradable PE wax from Allinova Company, used in printing inks, polishes, and
Cascara product consumption is anticipated to increase at a CAGR of around 10.4% through 2032
04-18-2024 | Food & Beverage
Fact.MR
Cascara product consumption is anticipated to increase at a CAGR of around 10.4% …
As per a new report by Fact.MR, a market research and competitive intelligence provider, the global cascara products market is currently valued at US$ 458 million and projected to expand at an impressive CAGR of 10.4% over the forecast period (2022 to 2032). The market registered 9.1% CAGR between 2017 and 2021. Fact.MR anticipates significant potential in the market due to the enhanced activity of market players across the coffee
Beauty Facial Mask Market Share to Reach US$ 11.2 Billion by 2032
Beauty Facial Mask Market Share to Reach US$ 11.2 Billion by 2032
According to Fact.MR, a market research and competitive intelligence provider, the global beauty facial mask (BFM) market is estimated at US$ 6.8 billion in 2022 and is expected to expand at an impressive CAGR of 5.1% during the forecast years of 2022-2032. A large number of elderly customers around the globe having the required buying power as well as the desire to appear younger, in turn increasing the demand for anti-aging

All 5 Releases


More Releases for Dermatological

Dermatological Drugs Market : Competitive Dynamics & Global Outlook 2031
Dermatological drugs Market - Overview The growth opportunities in the dermatological drugs market are growing at a noticeable speed due to numerous factors. Amongst these key factors, are the fungus, parasites, and some other microorganisms that are living on the skin. The bacteria are generally trapped in hair follicles and skin pores hold numerous fluids and prevent dehydration. These factors are estimated to fuel novel revenue generation opportunities in the market
Dermatological Drugs Market 2021: Global Industry Analysis Report to 2027
The global dermatological drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various diseases related to skin, nails, and hair, such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also known as dermatological, are products that are applied topically on the skin. These products are used to treat
Dermatological Drugs Market Report 2021-2031 - newly published
This new report will cover these areas: Forecasts by Disease (Psoriasis, Dermatitis, Acne, Skin Infections, Other Diseases), by Skin Infections Drugs (Bepanthen/Bepanthol, Protopic, Dermovate), by Psoriasis Drugs (Humira, Stelara, Enbrel, Remicade, Taltz, Otezla), by Dermatitis Drugs (Cubicin, Zyvox, Valtrex, Canesten, Lamisil, Other Dermatitis Drugs), by Route of Administration (Topical, Oral, Parenteral Administration) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Dermatological Drugs Companies AND COVID-19 Recovery Scenarios. What
Newly Released Visiongain Report: Dermatological Drugs Market Forecast 2020-2030
Psoriasis, Skin Infection, Acne, Dermatitis, Others To find out more about this report, click the link: https://www.visiongain.com/report/dermatological-drugs-market-forecast-2020-2030/ The revenue of the dermatological drugs market in 2018 is estimated at $31bn and is expected to grow at a CAGR of 3.7% in the first half of the forecast period. Psoriasis drugs segment accounted for the largest share of the market in 2018, this segment accounted for 38% of the global dermatological drugs market. How this
Dermatological Disorders Medications Market Size, Share, Development by 2024
New report published by Global Info Research which offers insights on the Global Dermatological Disorders Medications market. Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-dermatological-disorders-medications-market_p103576.html Global Dermatological Disorders Medications Market: Forecast by Type / Application / Region The worldwide market for Dermatological Disorders Medications is
Global Dermatological Devices Market
The Global Dermatological Devices Market was valued at US$ 6,565.5 million in 2015 and is projected to expand at a CAGR of 7.6% during the forecast period (2016–2024),as highlighted in a new report published by Coherent Market Insights.Rise in number of patients suffering from non-melanoma and melanoma skin cancers is expected to be one of the major factor to drive the dermatology devices market in the near future. According to